Compugen Ltd (NASDAQ: CGEN) started the day on Wednesday, with a price increase of 3.25% at $1.59, before settling in for the price of $1.54 at the close. Taking a more long-term approach, CGEN posted a 52-week range of $0.70-$3.03.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 94.22% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 12.14%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 82.54%. This publicly-traded company’s shares outstanding now amounts to $89.54 million, simultaneously with a float of $84.72 million. The organization now has a market capitalization sitting at $142.37 million. At the time of writing, stock’s 50-day Moving Average stood at $1.6555, while the 200-day Moving Average is $1.9732.
Compugen Ltd (CGEN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Compugen Ltd’s current insider ownership accounts for 5.38%, in contrast to 13.44% institutional ownership.
Compugen Ltd (CGEN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Compugen Ltd’s EPS increase for this current 12-month fiscal period is 82.54% and is forecasted to reach -0.17 in the upcoming year.
Compugen Ltd (NASDAQ: CGEN) Trading Performance Indicators
Let’s observe the current performance indicators for Compugen Ltd (CGEN). It’s Quick Ratio in the last reported quarter now stands at 4.14. The Stock has managed to achieve an average true range (ATR) of 0.11. Alongside those numbers, its PE Ratio stands at $82.81, and its Beta score is 2.60. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.38.
In the same vein, CGEN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.02, a figure that is expected to reach 0.07 in the next quarter, and analysts are predicting that it will be -0.17 at the market close of one year from today.
Technical Analysis of Compugen Ltd (CGEN)
If we take a close look at the recent performances of Compugen Ltd (NASDAQ: CGEN), its last 5-days Average volume was 0.59 million that shows progress from its year to date volume of 0.41 million. During the previous 9 days, stock’s Stochastic %D was recorded 54.90% While, its Average True Range was 0.1112.
Raw Stochastic average of Compugen Ltd (CGEN) in the period of the previous 100 days is set at 30.97%, which indicates a major fall in contrast to 66.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 64.00% that was higher than 57.75% volatility it exhibited in the past 100-days period.
